Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2010
04/08/2010WO2010039787A1 Compositions for use in identification of clostridium difficile
04/08/2010WO2010039778A2 Mammalian genes involved in infection
04/08/2010WO2010039775A1 Compositions for use in identification of members of the bacterial class alphaproteobacter
04/08/2010WO2010039763A2 Compositions for use in identification of antibiotic-resistant bacteria
04/08/2010WO2010039755A1 Compositions for use in identification of members of the bacterial genus mycoplasma
04/08/2010WO2010039696A1 Compositions for use in identification of herpesviruses
04/08/2010WO2010039649A2 Flavivirus-based system for production of hepatitis c virus (hcv)
04/08/2010WO2010039526A1 Genes and single nucleotide polymorphisms for genetic testing in bipolar disorder
04/08/2010WO2010039502A2 Micrornas in idiopathic pulmonary fibrosis
04/08/2010WO2010039275A1 Method, array and system for detecting intergenic fusions
04/08/2010WO2010039195A2 Screening for inhibitors of hcv amphipathic helix (ah) function
04/08/2010WO2010039189A2 Methods for sequencing degraded or modified nucleic acids
04/08/2010WO2010039180A2 High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
04/08/2010WO2010038840A1 METHOD FOR PREDICTING PHARMACOLOGICAL EFFICACY OF ANTI-TNFα ANTIBODY PREPARATION ON RHEUMATOID ARTHRITIS, AND PHARMACOLOGICAL EFFICACY PREDICTION APPARATUS
04/08/2010WO2010038789A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same
04/08/2010WO2010038228A2 Method and system for emitting light
04/08/2010WO2010038191A1 Method for testing and quality controlling of nucleic acids on a support
04/08/2010WO2010038170A1 Method for immobilizing nucleic acids on a support
04/08/2010WO2010038083A2 Transcription factor decoys
04/08/2010WO2010038050A1 Sample measurement system
04/08/2010WO2010038044A2 Imaging techniques
04/08/2010WO2010038042A1 Nucleic acid sample enrichment for sequencing applications
04/08/2010WO2010038032A1 Genetic test for liver copper accumulation in dogs and low copper pet diet
04/08/2010WO2010037908A1 Method and apparatus for detecting elution of samples
04/08/2010WO2010037907A1 Method and apparatus for detecting undesired measurement conditions
04/08/2010WO2010037859A2 Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
04/08/2010WO2010037735A1 Molecular markers in prostate cancer
04/08/2010WO2010037207A1 Selective glycosidase inhibitors and uses thereof
04/08/2010WO2010037184A1 Diagnostic markers for ankylosing spondylitis
04/08/2010WO2010037181A1 Cell therapy and compositions therefor
04/08/2010WO2010022328A3 Genetic loci associated with head smut resistance in maize
04/08/2010WO2010019386A3 Protein production in plant cells and associated methods and compositions
04/08/2010WO2010015538A3 Predictive marker for egfr inhibitor treatment
04/08/2010WO2010015423A3 Methods for plant fiber characterization and identification
04/08/2010WO2010011965A3 Identifying high risk clinically isolated syndrome patients
04/08/2010WO2010009203A3 Lateral flow nucleic acid detector
04/08/2010WO2010002949A3 Remote optical switch for localized control of gene interference
04/08/2010WO2010002938A3 Method for direct amplification from crude nucleic acid samples
04/08/2010WO2009154710A3 Multi-dimensional fluid sensors and related detectors and methods
04/08/2010WO2009150241A3 Eif2 gamma gene as a diagnostic target for the identification of fungal and yeast species
04/08/2010WO2009140601A3 Genetic marker weight management
04/08/2010WO2009139919A3 Methods for diagnosis of clostridium diffcile and methods and vectors for recombinant toxin expression
04/08/2010WO2009138146A3 Novel therapeutic agents against hepatitis
04/08/2010WO2009137137A3 Optimized probes and primers and methods of using same for the detection and quantitation of bk virus
04/08/2010WO2009117122A8 Genetic analysis
04/08/2010WO2009093213A3 Method for predicting and diagnosing brain tumor
04/08/2010US20100088778 Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
04/08/2010US20100088773 Mutations in lama2 gene of zebrafish
04/08/2010US20100087724 Membrane for use with implantable devices
04/08/2010US20100087722 Small Volume In Vitro Analyte Sensor and Methods of Making
04/08/2010US20100087641 Method and Materials for Quaternary Amine Catalyzed Bisulfite Conversion of Cytosine to Uracil
04/08/2010US20100087630 Use of XCR1 for Diagnosing or Monitoring of Immune Tolerance
04/08/2010US20100087522 Novel muscle relaxant using negative charge gold nanoparticle with choline
04/08/2010US20100087513 Microrna molecules
04/08/2010US20100087512 Microrna molecules
04/08/2010US20100087508 Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
04/08/2010US20100087493 Method for improving the pharmacokinetics of drugs metabolized by ugt2b10
04/08/2010US20100087471 Indole and indoline derivatives and methods of use thereof
04/08/2010US20100087462 Methods for predicting and detecting intolerance to an hypolipidemic agent
04/08/2010US20100087441 Prognostic Method
04/08/2010US20100087421 Method to determine the risk for side effects of an ssri treatment in a person
04/08/2010US20100087377 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; copper binding protein; inhibit the development of premalignant lesions in mammalian tissue
04/08/2010US20100087376 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
04/08/2010US20100087375 Modulation of synaptogenesis
04/08/2010US20100087362 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
04/08/2010US20100087335 siRNA targeting spleen tyrosine kinase
04/08/2010US20100087331 Method of nucleic acid analysis
04/08/2010US20100087328 Brm expression and related diagnostics
04/08/2010US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
04/08/2010US20100086977 Pressure Chamber Clamp Mechanism
04/08/2010US20100086964 Apparatus and method for identifying at least one specimen slide
04/08/2010US20100086963 Automated seed sampler and methods of sampling, testing and bulking seeds
04/08/2010US20100086962 Hematology controls and methods
04/08/2010US20100086961 Small Volume In Vitro Analyte Sensor and Methods of Making
04/08/2010US20100086960 Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states
04/08/2010US20100086959 Filtration unit and method for the microbiological analysis of liquid samples
04/08/2010US20100086958 Novel enzyme
04/08/2010US20100086957 Method for monitoring intracellular tyrosine phosphatase activity
04/08/2010US20100086956 Detection of hiv-related proteins in urine
04/08/2010US20100086955 Small Molecule Inhibitors of Ghrelin O-Acyltransferase
04/08/2010US20100086954 Small Volume In Vitro Analyte Sensor and Methods of Making
04/08/2010US20100086953 Blood Coagulation Assays
04/08/2010US20100086949 Retentate chromatography and protein chip arrays with applications in biology and medicine
04/08/2010US20100086947 Use of flow-cytrometric analysis to optimize cell banking strategies for cho cells
04/08/2010US20100086944 Methods and Compositions for Diagnosis and Prognosis of Renal Artery Stenosis
04/08/2010US20100086936 Hepatocyte precursor cell lines
04/08/2010US20100086935 Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles
04/08/2010US20100086934 Use of non-clonal chromosomal aberrations for cancer research and clinical diagnosis
04/08/2010US20100086933 Sensor for detecting an analyte
04/08/2010US20100086932 Bladder cancer diagnosis and/or prognosis method
04/08/2010US20100086931 Method for assaying action of antitumor agent using decrease in gene expression level as index
04/08/2010US20100086930 Improved homogeneous luminescence bioassay
04/08/2010US20100086929 Detection of analytes
04/08/2010US20100086928 Detection of organ rejection
04/08/2010US20100086927 Deposition of metal oxides onto surfaces as an immobilization vehicle for carboxylated or phophated particles or polymers
04/08/2010US20100086926 Method of characterizing sequences from genetic material samples
04/08/2010US20100086925 Microfluidic structure for multi-assay and microfluidic device comprising the same
04/08/2010US20100086924 Use of tde for isolation of nucleic acids
04/08/2010US20100086923 Use of acetals for isolation of nucleic acids
04/08/2010US20100086922 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment